Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYDROSAPL
2017-004866-86Phase 2Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Obstetrical antiphospholipid syndrome (OAPS) and antiphospholipid syndrome (APS) comparing Plaquenil + usual medical care with Placebo + usual medical care (2 arms). Primary endpoint: Percentage of uncomplicated term pregnancies with a eutrophic child. Started Dec 2020; status: active.
02
Drugs
hydroxychloroquine
03
Conditions
Obstetrical antiphospholipid syndrome (OAPS)antiphospholipid syndrome (APS)
Beyond the preview
Go deeper on 2017-004866-86.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004866-86.